Literature DB >> 21118944

Hospital surveillance of childhood bacterial meningitis in Senegal and the introduction of Haemophilus influenzae type b conjugate vaccine.

Osseynou Ba1, Jessica A Fleming, Yakou Dieye, Boniface Mutombo wa Mutombo, Mamadou Ba, Moussa Fafa Cisse, Aissatou Gaye Diallo, Iyane Sow, Mary P E Slack, Pape Coumba Faye, Mady Ba, Ndiouga Diallo, Noel S Weiss.   

Abstract

Bacterial meningitis is an important cause of morbidity and mortality in children living in low-resource settings. Pediatric bacterial meningitis cases < 5 years of age were identified through a regional hospital surveillance system for 3 years after introduction of routine immunization with Haemophilus influenzae type b (Hib) conjugate vaccine in Senegal in July 2005. Cases from the national pediatric hospital were also tracked from 2002 to 2008. The regional surveillance system recorded 1,711 suspected pediatric bacterial meningitis cases. Of 214 laboratory-confirmed cases, 108 (50%) were caused by Streptococcus pneumoniae, 42 (20%) to Hib, and 13 (6%) to Neisseria meningitidis. There was a 98% reduction in the number of hospitalized Hib meningitis cases from Dakar Region in 2008 compared with 2002. The surveillance system provides important information to the Ministry of Health as they consider self-funding Hib vaccine and introducing pneumococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118944      PMCID: PMC2990054          DOI: 10.4269/ajtmh.2010.10-0346

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda.

Authors:  Narcisse Muganga; Jeannine Uwimana; Ngabo Fidele; Laetitia Gahimbare; Bradford D Gessner; Judith E Mueller; Bekithemba R Mhlanga; Reggis Katsande; Karl-Heinz Herbinger; Celse Rugambwa
Journal:  Vaccine       Date:  2007-07-05       Impact factor: 3.641

Review 2.  Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.

Authors:  Bradford D Gessner
Journal:  Expert Rev Vaccines       Date:  2009-01       Impact factor: 5.217

3.  Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.

Authors:  Karen D Cowgill; Moses Ndiritu; Joyce Nyiro; Mary P E Slack; Salome Chiphatsi; Amina Ismail; Tatu Kamau; Isaiah Mwangi; Mike English; Charles R J C Newton; Daniel R Feikin; J Anthony G Scott
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

4.  Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.

Authors:  Richard A Adegbola; Ousman Secka; George Lahai; Nellie Lloyd-Evans; Alpha Njie; Stanley Usen; Claire Oluwalana; Stephen Obaro; Martin Weber; Tumani Corrah; Kim Mulholland; Keith McAdam; Brian Greenwood; Paul J M Milligan
Journal:  Lancet       Date:  2005 Jul 9-15       Impact factor: 79.321

5.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group.

Authors: 
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

6.  Bacteremia among children admitted to a rural hospital in Kenya.

Authors:  James A Berkley; Brett S Lowe; Isaiah Mwangi; Thomas Williams; Evasius Bauni; Saleem Mwarumba; Caroline Ngetsa; Mary P E Slack; Sally Njenga; C Anthony Hart; Kathryn Maitland; Mike English; Kevin Marsh; J Anthony G Scott
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

Review 7.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

8.  Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.

Authors:  A von Gottberg; L de Gouveia; S A Madhi; M du Plessis; V Quan; K Soma; R Huebner; B Flannery; A Schuchat; Kp Klugman
Journal:  Bull World Health Organ       Date:  2006-10       Impact factor: 9.408

9.  Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.

Authors:  Samba O Sow; Milagritos D Tapia; Souleymane Diallo; Mamadou Marouf Keita; Mariam Sylla; Uma Onwuchekwa; Marcela F Pasetti; Karen L Kotloff; Myron M Levine
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

10.  Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.

Authors:  Guilherme S Ribeiro; Joice N Reis; Soraia M Cordeiro; Josilene B T Lima; Edilane L Gouveia; Maya Petersen; Kátia Salgado; Hagamenon R Silva; Rosemeire Cobo Zanella; Samanta C Grassi Almeida; Maria Cristina Brandileone; Mitermayer G Reis; Albert I Ko
Journal:  J Infect Dis       Date:  2002-12-13       Impact factor: 5.226

View more
  8 in total

Review 1.  Childhood pneumococcal disease in Africa - A systematic review and meta-analysis of incidence, serotype distribution, and antimicrobial susceptibility.

Authors:  Pui-Ying Iroh Tam; Beth K Thielen; Stephen K Obaro; Ann M Brearley; Alexander M Kaizer; Haitao Chu; Edward N Janoff
Journal:  Vaccine       Date:  2017-03-09       Impact factor: 3.641

2.  Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniae NP carriage and IPD in Dakar.

Authors:  Fatim Ba; Abdoulaye Seck; Mamadou Bâ; Aliou Thiongane; Moussa Fafa Cissé; Khady Seck; Madeleine Ndour; Pascal Boisier; Benoit Garin
Journal:  BMC Infect Dis       Date:  2014-12-04       Impact factor: 3.090

3.  Prevalence and antibiotic resistance profiles of cerebrospinal fluid pathogens in children with acute bacterial meningitis in Yunnan province, China, 2012-2015.

Authors:  Hongchao Jiang; Min Su; Liyue Kui; Hailin Huang; Lijuan Qiu; Li Li; Jing Ma; Tingyi Du; Mao Fan; Qiangming Sun; Xiaomei Liu
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 4.  Challenges in the Etiology and Diagnosis of Acute Febrile Illness in Children in Low- and Middle-Income Countries.

Authors:  Pui-Ying Iroh Tam; Stephen K Obaro; Gregory Storch
Journal:  J Pediatric Infect Dis Soc       Date:  2016-04-07       Impact factor: 3.164

5.  Estimating the global and regional burden of meningitis in children caused by Haemophilus influenzae type b: A systematic review and meta-analysis.

Authors:  Jay J Park; Sandhya Narayanan; Jakov Tiefenbach; Ivana Lukšić; Boni Maxime Ale; Davies Adeloye; Igor Rudan
Journal:  J Glob Health       Date:  2022-03-05       Impact factor: 4.413

6.  A systematic review and meta-analysis of the aetiological agents of non-malarial febrile illnesses in Africa.

Authors:  Martin Wainaina; David Attuy Vey da Silva; Ian Dohoo; Anne Mayer-Scholl; Kristina Roesel; Dirk Hofreuter; Uwe Roesler; Johanna Lindahl; Bernard Bett; Sascha Al Dahouk
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

7.  Aetiological agents of cerebrospinal meningitis: a retrospective study from a teaching hospital in Ghana.

Authors:  Michael Owusu; Samuel Blay Nguah; Yaw Agyekum Boaitey; Ernest Badu-Boateng; Abdul-Raman Abubakr; Robert Awuley Lartey; Yaw Adu-Sarkodie
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-10-04       Impact factor: 3.944

8.  Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.

Authors:  Mouhamadou A Sonko; Felix S Dube; Catherine Bi Okoi; Amadou Diop; Aliou Thiongane; Madikay Senghore; Peter Ndow; Archibal Worwui; Papa M Faye; Baidy Dieye; Idrissa D Ba; Aliou Diallo; Diop Boly; Ousmane Ndiaye; Moussa F Cissé; Jason M Mwenda; Brenda A Kwambana-Adams; Martin Antonio
Journal:  Clin Infect Dis       Date:  2019-09-05       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.